Citation: A. Otte et G. Mahler, Adapted-operator representations: Selective versus collective properties of quantum networks - art. no. 012303, PHYS REV A, 6201(1), 2000, pp. 2303
Authors:
Meiner, SM
Otte, A
Schumacher, M
Brink, I
Juengling, FD
Sobanksi, T
Nitzsche, EU
Peter, HH
Citation: Sm. Meiner et al., Alterations of cerebral glucose metabolism indicate progress to severe morphological brain lesions in neuropsychiatric systemic lupus erythematosus, LUPUS, 9(5), 2000, pp. 386-389
Authors:
Weiner, SM
Otte, A
Schumacher, M
Juengling, FD
Brink, I
Nitzsche, EU
Peter, HH
Kreisel, W
Citation: Sm. Weiner et al., Neuro-Behcet's syndrome in a patient not fulfilling criteria for Behcet's disease: Clinical features and value of brain imaging, CLIN RHEUMA, 19(3), 2000, pp. 231-234
Citation: J. Kassubek et al., Improved interpretation of cerebral PET with respect to structural MRI changes using combined voxel-based statistical mapping, EUR J NUCL, 27(7), 2000, pp. 880-880
Authors:
Weiner, SM
Otte, A
Schumacher, M
Klein, R
Gutfleisch, J
Brink, I
Otto, P
Nitzsche, EU
Moser, E
Peter, HH
Citation: Sm. Weiner et al., Diagnosis and monitoring of central nervous system involvement in systemiclupus erythematosus: value of F-18 fluorodeoxyglucose PET, ANN RHEUM D, 59(5), 2000, pp. 377-385
Authors:
Merlo, A
Hausmann, O
Wasner, M
Steiner, P
Otte, A
Jermann, E
Freitag, P
Reubi, JC
Muller-Brand, J
Gratzl, O
Macke, HR
Citation: A. Merlo et al., Locoregional regulatory peptide receptor targeting with the diffusible somatostatin analogue Y-90-labeled DOTA(0)-D-Phe(1)-Tyr(3)-octreotide (DOTATOC): A pilot study in human gliomas, CLIN CANC R, 5(5), 1999, pp. 1025-1033
Citation: A. Otte, PET with (18)fluorodeoxyglucose and hexamethylpropylene amine oxime SPECT in late whiplash syndrome, NEUROLOGY, 52(5), 1999, pp. 1107-1108